LONDON DAILY ARCHIVE

Cancer Cells Thwart RAS Therapies

Memorial Sloan Kettering (MSK) researchers successfully uncovered the exact structural mechanisms cancer cells use to evade new "molecular glue" drugs targeting RAS mutations, opening the door for highly targeted combination therapies.

27 May 2026 · 06:22 UTC